• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: CureToday articles Experts at Hackensack Meridian Jersey Shore University Medical Center have successfully treated their first patients using the TAMP™ therapy platform. Read More

How I Manage When My Social Media Friends with Cancer Disappear

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: CureToday articles I stay in the cancer social media world because it helps me cope, even when friends disappear and I’m left wondering if they’re resting, retreating or gone. Read More

U.S. Centers Seek Namodenoson for Pancreatic Cancer Compassionate Use

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: CureToday articles U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for patients with pancreatic cancer. Read More

Emactuzumab Gets Fast Track Designation in Tenosynovial Giant Cell Tumors

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: CureToday articles Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery. Read More

Raising Awareness on Multidisciplinary Approaches in GI Cancers

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: CureToday articles Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert. Read More

Optimizing Oncology Clinical Pathways at the Point of Care

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: ASCO Daily News Dr. John Sweetenham, Dr. Larry Shulman, and Dr. Rebecca Maniago discuss the integration of clinical pathways and decision support tools into the cancer center workflow, challenges to implementation at the point of care, and the promise of AI to...
« Older Entries
Next Entries »

Recent Content

  • Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma
  • The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma
  • FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma
  • FDA accelerates linvoseltamab-gcpt approval for multiple myeloma
  • Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and immunotherapy biomarkers
  • The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Spatial and single cell mapping of castleman disease reveals key stromal cell types and cytokine pathways
  • Managing IEC-associated enterocolitis following CAR-T therapy in multiple myeloma
  • What Should Patients with Multiple Myeloma Know After ASCO 2025?
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT